To cite this paper use one of the standards below:
INTRODUCTION AND OBJECTIVES: Smoking is a risk factor for the development of several types of cancers due to the presence of carcinogens in cigarette smoke. It has already been demonstrated that nicotine, the main addictive component of cigarettes, has a fundamental role in cancer initiation and progression since it promotes survival, proliferation, resistance to therapy and activation of epithelial-mesenchymal transition (EMT) program. The epithelial-mesenchymal transition occurs by the loss of the epithelial phenotype of cancer cells and acquisition of mesenchymal characteristics - such as increased invasion capacity and motility - which confers to cancer the ability to establish metastasis. In addition, studies have already demonstrated the potential of nicotine in inducing multiple drug resistance (MDR), a phenotype that is the main obstacle in cancer treatment. Furthemore, it is observed that cancer cells have a differentiated glycosylation pattern when compared to normal cells, and this glicophenotypic alteration is capable of inducing metastasis and drug resistance. The literature has already described the potential of nicotine in modulating the intracellular phenotype of glycosylation, but its action on extracellular glycosylation has never been investigated. Thus, the general objective of this work is to evaluate the impact of chronic treatment with nicotine on the extracellular glycophenotype of lung cancer tumor cells and how this affects tumor progression. MATERIAL AND METHODS: First, through the MTT assay, we found the concentrations of IC-20 and IC-50 of the A549 lung adenocarcinoma cell line, which were 3mM and 12mM, respectively. Thereafter, the cells were submitted to chronic treatment with nicotine for 1 month. Subsequently, we analyzed the acquisition of resistance not only to nicotine but also to the chemotherapeutic agents cisplatin and doxorubicin in parental and nicotine-treated cells through the MTT assay. In addition, using flow cytometry, with the help of lectins, we compared the glycophenotype of nicotine-treated and parental cells. RESULTS AND CONCLUSION: Glycophenotypic analysis revealed reduced expression of the epitope Galβ1-3GalNAc, monitored by Peanut agglutinin lectin (PNA), as well as bisected N-linked glycans, which were investigated with the lectin Phaseolus vulgaris erythroagglutinin (PHA-E). Regarding the O-linked glycans, it was observed an increase in the expression of Tn antigen, which was evidenced by the Helix pomatia lectin (HPA), suggesting that these glycans, in the cells treated with nicotine, were truncated. Taking together these preliminary data indicate that there is accumulation of truncated O-linked glycans and reduced expression of sialoglycans, as well as tri or tetra-antennary and bisected N-glycans. New experiments are underway in our laboratory to better understand the impact of these changes on glycosylation in cells chronically exposed to the carcinogen nicotine.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper